Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosis

Light chain (AL) amyloidosis is a plasma cell neoplasm associated with insoluble fibril deposition from clonal immunoglobulin chains systemically. The disease is associated with high early mortality and morbidity owing to advanced organ deposition as well as lack of proven de-fibrillogenic therapies...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contemp Clin Trials Commun
Main Authors: D'Souza, Anita, Flynn, Kathryn, Chhabra, Saurabh, Dhakal, Binod, Hamadani, Mehdi, Jacobsen, Kirsten, Pasquini, Marcelo, Weihrauch, Dorothee, Hari, Parameswaran
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5898504/
https://ncbi.nlm.nih.gov/pubmed/29696194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2017.08.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados